Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Buti

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Gastroenterologia Y Hepatologia|July 4, 2012
[Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection (2012)]María Buti, Javier García-Samaniego, Martín Prieto, et al.
Journal of Hepatology|December 4, 2018
Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?Mar Riveiro-Barciela, Eva Muñoz-Couselo, Jesús Fernandez-Sojo, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|October 26, 2014
[Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients]María Buti, Blanca Gros, Itziar Oyagüez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2023
The significant IgG4 infiltrate in autoimmune hepatitis is associated with a greater ductular reaction and more advanced liver diseaseAna Barreira-Díaz, María Teresa Salcedo-Allende, Fernando Martínez-Valle, et al.
Gastroenterologia Y Hepatologia|September 9, 2024
Clinical and economic value of bulevirtide in the treatment of chronic hepatitis DMaría Buti, Jose Luis Calleja, Miguel Ángel Rodríguez, et al.
Gastroenterologia Y Hepatologia|May 16, 2015
[Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice]Javier Crespo, Marina Berenguer, Francisco Pérez, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2026
Emergency Department Screening Reveals Declining HCV Viraemia but Stable HBV Prevalence in Western Europe: A Sentinel Surveillance OpportunityLena Vargas-Accarino, Murad Ruf, Liam Townsend, et al.
Journal of Hepatology|April 14, 2005
Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis CMaría Buti, Ramón San Miguel, Max Brosa, et al.
Scientific Reports|February 22, 2020
An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disordersMar Riveiro-Barciela, Paula Gubern, Luisa Roade, et al.
Gastroenterologia Y Hepatologia|March 13, 2026
Consensus document on the diagnosis, management, and treatment of chronic hepatitis B virus and hepatitis D virus infection in SpainSabela Lens, Federico García, Juanjo Mascort, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Gastroenterologia Y Hepatologia|July 4, 2012
[Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection (2012)]María Buti, Javier García-Samaniego, Martín Prieto, et al.
Journal of Hepatology|December 4, 2018
Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?Mar Riveiro-Barciela, Eva Muñoz-Couselo, Jesús Fernandez-Sojo, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|October 26, 2014
[Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients]María Buti, Blanca Gros, Itziar Oyagüez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2023
The significant IgG4 infiltrate in autoimmune hepatitis is associated with a greater ductular reaction and more advanced liver diseaseAna Barreira-Díaz, María Teresa Salcedo-Allende, Fernando Martínez-Valle, et al.
Gastroenterologia Y Hepatologia|September 9, 2024
Clinical and economic value of bulevirtide in the treatment of chronic hepatitis DMaría Buti, Jose Luis Calleja, Miguel Ángel Rodríguez, et al.
Gastroenterologia Y Hepatologia|May 16, 2015
[Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice]Javier Crespo, Marina Berenguer, Francisco Pérez, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2026
Emergency Department Screening Reveals Declining HCV Viraemia but Stable HBV Prevalence in Western Europe: A Sentinel Surveillance OpportunityLena Vargas-Accarino, Murad Ruf, Liam Townsend, et al.
Journal of Hepatology|April 14, 2005
Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis CMaría Buti, Ramón San Miguel, Max Brosa, et al.
Scientific Reports|February 22, 2020
An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disordersMar Riveiro-Barciela, Paula Gubern, Luisa Roade, et al.
Gastroenterologia Y Hepatologia|March 13, 2026
Consensus document on the diagnosis, management, and treatment of chronic hepatitis B virus and hepatitis D virus infection in SpainSabela Lens, Federico García, Juanjo Mascort, et al.
Pageof 10